TG Therapeutics (TGTX) PT Lowered to $20 at Ladenburg Thalmann
Tweet
Share
E-mail
Get Alerts TGTX Hot Sheet
Price: $55.99 +0.02%
Rating Summary:
12 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 24 | Down: 22 | New: 31
Rating Summary:
12 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 24 | Down: 22 | New: 31
Join SI Premium – FREE
Ladenburg Thalmann analyst Matthew Kaplan lowered the price target on TG Therapeutics (NASDAQ: TGTX) to $20.00 (from $47.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Climb Bio (CLYM) PT Raised to $30 at H.C. Wainwright
- Merck (MRK) PT Raised to $170 at Guggenheim
- Hinge Health Inc (HNGE) PT Raised to $115 at Stifel on Selling Season Yields
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
